Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Nov-19 7:31 AM View:  | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 327 | -- | -- | (100%) 0.33K to 0 | |
| 22-Nov-19 7:30 AM View: | Bonney Michael W Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 2,209 | -- | -- | (52%) 4.21K to 2.0K | |
| 22-Nov-19 7:31 AM View: | Alles Mark J CEO, CHAIRMAN OF BOARD Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 366,495 | -- | -- | (98%) 372.75K to 6.25K | |
| 22-Nov-19 7:31 AM View: | Vessey Rupert PRES., RESEARCH AND EARLY DEV. | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 613 | -- | -- | (100%) 0.61K to 0 | |
| 22-Nov-19 7:30 AM View: | Mario Ernest Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 4,908 | -- | -- | (100%) 4.91K to 0 | |
| 22-Nov-19 7:31 AM View: | Biller Jonathan EVP and General Counsel | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 878 | -- | -- | (100%) 0.88K to 0 | |
| 22-Nov-19 7:30 AM View: | Cox Carrie Smith Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 39,535 | -- | -- | (100%) 39.53K to 0 | |
| 22-Nov-19 7:31 AM View: | Elkins David V EVP, CHIEF FINANCIAL OFFICER | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 195 | -- | -- | (100%) 0.2K to 0 | |
| 22-Nov-19 7:30 AM View: | Casey Michael D Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 143,638 | -- | -- | (100%) 143.64K to 0 | |
| 22-Nov-19 7:31 AM View: | Reicin Alise PRES., GLOBAL CLINICAL DEV. | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 37,434 | -- | -- | 521% 7.18K to 44.62K | |
| 22-Nov-19 7:30 AM View: | Weiland John H Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 5,575 | -- | -- | (100%) 5.58K to 0 | |
| 22-Nov-19 7:31 AM View: | Ahmed Nadim PRES., GLOBAL HEM. AND ONC. | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 1,966 | -- | -- | (100%) 1.97K to 0 | |
| 22-Nov-19 7:31 AM View: | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 32,868 | -- | -- | 708% 4.64K to 37.51K | |
| 22-Nov-19 7:31 AM View: | Vessey Rupert PRES., RESEARCH AND EARLY DEV. | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 46,749 | -- | -- | 316% 14.79K to 61.54K | |
| 22-Nov-19 7:30 AM View: | Bonney Michael W Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 2,000 | -- | -- | (100%) 2.0K to 0 | |
| 22-Nov-19 7:31 AM View: | Alles Mark J CEO, CHAIRMAN OF BOARD Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 6,252 | -- | -- | (100%) 6.25K to 0 | |
| 22-Nov-19 7:30 AM View: | Barker Richard W Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 13,337 | -- | -- | (100%) 13.34K to 0 | |
| 22-Nov-19 7:31 AM View: | Biller Jonathan EVP and General Counsel | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 20,387 | -- | -- | 285% 7.14K to 27.53K | |
| 22-Nov-19 7:31 AM View: | Elkins David V EVP, CHIEF FINANCIAL OFFICER | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 43,224 | -- | -- | 306% 14.1K to 57.33K | |
| 22-Nov-19 7:30 AM View: | Loughlin James J Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 41,861 | -- | -- | (96%) 43.66K to 1.8K | |
| 22-Nov-19 7:31 AM View: | Reicin Alise PRES., GLOBAL CLINICAL DEV. | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 44,615 | -- | -- | (100%) 44.62K to 0 | |
| 22-Nov-19 7:31 AM View: | Ahmed Nadim PRES., GLOBAL HEM. AND ONC. | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 25,875 | -- | -- | 154% 16.79K to 42.66K | |
| 22-Nov-19 7:31 AM View: | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 37,181 | -- | -- | (99%) 37.51K to 0.33K | |
| 22-Nov-19 7:31 AM View: | Alles Mark J CEO, CHAIRMAN OF BOARD Director | Celgene Corporation (CELG) | 20-Nov-19 | Grant | 145,229 | -- | -- | 64% 227.52K to 372.75K | |
| 22-Nov-19 7:31 AM View: | Vessey Rupert PRES., RESEARCH AND EARLY DEV. | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 60,927 | -- | -- | (99%) 61.54K to 0.61K | |
| 22-Nov-19 7:30 AM View: | Mario Ernest Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 62,884 | -- | -- | (93%) 67.79K to 4.91K | |
| 22-Nov-19 7:30 AM View: | Friedman Michael A Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 19,847 | -- | -- | (100%) 19.85K to 0 | |
| 22-Nov-19 7:31 AM View: | Biller Jonathan EVP and General Counsel | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 26,652 | -- | -- | (97%) 27.53K to 0.88K | |
| 22-Nov-19 7:30 AM View: | Haller Julia A Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 2,409 | -- | -- | (100%) 2.41K to 0 | |
| 22-Nov-19 7:31 AM View: | Elkins David V EVP, CHIEF FINANCIAL OFFICER | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 57,132 | -- | -- | (100%) 57.33K to 0.2K | |
| 22-Nov-19 7:30 AM View: | Loughlin James J Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 1,800 | -- | -- | (100%) 1.8K to 0 | |
| 22-Nov-19 7:31 AM View: | Ahmed Nadim PRES., GLOBAL HEM. AND ONC. | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 40,694 | -- | -- | (95%) 42.66K to 1.97K | |
| 22-Nov-19 7:30 AM View: | Bishop Hans Edgar Director | Celgene Corporation (CELG) | 20-Nov-19 | Disposition | 23,088 | -- | -- | (100%) 23.09K to 0 | |
| 04-Nov-19 4:05 PM View: | Reicin Alise PRES., GLOBAL CLINICAL DEV. | Celgene Corporation (CELG) | 01-Nov-19 | Option Exercise | 11,903 | -- | -- | 100% 0 to 11.9K | |
| 04-Nov-19 4:05 PM View: | Reicin Alise PRES., GLOBAL CLINICAL DEV. | Celgene Corporation (CELG) | 01-Nov-19 | Payment of Exercise | 4,722 | $108.53 | $512,479.00 | (40%) 11.9K to 7.18K | |
| 04-Nov-19 4:05 PM View: | Biller Jonathan EVP and General Counsel | Celgene Corporation (CELG) | 31-Oct-19 | Payment of Exercise | 1,044 | $108.03 | $112,783.00 | (13%) 8.19K to 7.14K | |
| 04-Nov-19 4:05 PM View: | Biller Jonathan EVP and General Counsel | Celgene Corporation (CELG) | 31-Oct-19 | Option Exercise | 3,125 | -- | -- | 62% 5.06K to 8.19K | |
| 04-Nov-19 4:05 PM View: | Curran Terrie SEE REMARKS | Celgene Corporation (CELG) | 31-Oct-19 | Payment of Exercise | 1,123 | $108.03 | $121,318.00 | (18%) 6.36K to 5.24K | |
| 04-Nov-19 4:05 PM View: | Ahmed Nadim PRES., GLOBAL HEM. AND ONC. | Celgene Corporation (CELG) | 31-Oct-19 | Payment of Exercise | 1,096 | $108.03 | $118,401.00 | (6%) 17.88K to 16.79K | |
| 04-Nov-19 4:05 PM View: | Vessey Rupert SEE REMARKS | Celgene Corporation (CELG) | 31-Oct-19 | Payment of Exercise | 2,644 | $108.03 | $285,631.00 | (15%) 17.43K to 14.79K | |
| 04-Nov-19 4:05 PM View: | Vessey Rupert SEE REMARKS | Celgene Corporation (CELG) | 31-Oct-19 | Option Exercise | 5,369 | -- | -- | 44% 12.07K to 17.43K | |
| 04-Nov-19 4:05 PM View: | Curran Terrie SEE REMARKS | Celgene Corporation (CELG) | 31-Oct-19 | Option Exercise | 3,281 | -- | -- | 106% 3.08K to 6.36K | |
| 04-Nov-19 4:05 PM View: | Ahmed Nadim PRES., GLOBAL HEM. AND ONC. | Celgene Corporation (CELG) | 31-Oct-19 | Option Exercise | 3,281 | -- | -- | 22% 14.6K to 17.88K | |
| 06-Nov-19 4:05 PM View: | Cox Carrie Smith Director | Celgene Corporation (CELG) | 29-Oct-19 | Option Exercise | 12,500 | $25.89 | $323,625.00 | 42% 30.08K to 42.58K | |
| 06-Nov-19 4:05 PM View: | Cox Carrie Smith Director | Celgene Corporation (CELG) | 29-Oct-19 | Payment of Exercise | 3,045 | $106.30 | $323,684.00 | (7%) 42.58K to 39.53K | |
| 19-Sep-19 4:05 PM View: | Curran Terrie SEE REMARKS | Celgene Corporation (CELG) | 18-Sep-19 | Market Option Sale | 4,500 | $98.27 | $442,199.00 | (31%) 14.42K to 9.92K | |
| 19-Sep-19 4:05 PM View: | Curran Terrie SEE REMARKS | Celgene Corporation (CELG) | 18-Sep-19 | Option Exercise | 4,500 | $58.33 | $262,485.00 | 45% 9.92K to 14.42K | |
| 19-Sep-19 4:05 PM View: | Curran Terrie SEE REMARKS | Celgene Corporation (CELG) | 18-Sep-19 | Market Sale | 6,838 | $98.27 | $671,945.00 | (69%) 9.92K to 3.08K | |
| 05-Aug-19 4:00 PM View: | Elkins David V EVP, CHIEF FINANCIAL OFFICER | Celgene Corporation (CELG) | 01-Aug-19 | Payment of Exercise | 11,039 | $93.05 | $1,027,180.00 | (44%) 25.14K to 14.1K | |
| 05-Aug-19 4:00 PM View: | Elkins David V EVP, CHIEF FINANCIAL OFFICER | Celgene Corporation (CELG) | 01-Aug-19 | Option Exercise | 24,947 | -- | -- | 12793% 0.2K to 25.14K |
